Eli Lilly

Teva to Drop Depression Treatment after Trial Fails

Eli Lilly 'Deeply Concerned' By Bribery Allegations in China

Eli Lilly Defends Blockbuster Alimta With Unusual Ammo

China to Launch Fresh Pharmaceutical Bribery Probe

China Investigates France's Sanofi for Alleged Bribery

Drug Makers Fear Short-Term Turmoil As China Probes Widen

China Widens Drug Industry Probe, Visits Belgium’s UCB

China Blocks GSK Finance Head From Leaving Country

Sanofi Steps up Diabetes Drive as Rivals Raise the Stakes

After Tech Success, Israel Seeks Life Sciences Growth

Eli Lilly CEO Recovering After Repair to Aorta

Eli Lilly Broadens Diabetes Offer

U.S. Launch of Novo's New Insulin Faces Long Delay

Strong Pet Product Sales Help Zoetis Top Estimates

Drugmaker Eli Lilly to Cut 1,000 U.S. Sales Jobs

U.S. Struggles with Pharmaceutical Goals in Asia Trade Talks

Antibiotics Crisis Prompts Rethink on Risks, Rewards

Obama Medicare Rebate Plan Could Hurt Drug Companies

Amgen Biosimilar Push Takes Aim at Blockbusters

Zoetis IPO Prices at $26; Largest US Deal Since Facebook

Eli Lilly Q4 Profits Hurt by Generic Competition

Drug Industry Bets on New Blockbusters in 2013

Eli Lilly Banks on Cost Controls for Higher 2013 Profit

Eli Lilly to Pay $29 Million to Settle US SEC Bribery Case

Drug Industry Treading Water on R&D Productivity

White House Said to Be Frustrating US Drug Companies in Asia Trade Talks

Topics • Technology

Thriving Generics

Changing Times

AstraZeneca Buys Equal Say over Amylin Drugs

Eli Lilly Raises 2012 Net Profit Forecast

Generics Seen Cutting into Drug Sales Growth through 2016

Survey Shows Dim Faith in Lilly, Pfizer Alzheimer's Drugs

Lilly Resumes Share Buybacks After Long Absence

US Top Court Rules for Glaxo on Overtime Pay

Bristol, AstraZeneca among Amylin Bidders

27 more articles

Top-Feature

Bio-Rad Laboratories

Dual‑Targeting Breakthroughs: Advancements in Bispecific Antibody Development

JMP Statistical Discovery / SAS Institute GmbH

From Data to Decisions: Digital Tools Reshaping the Chemical and Life Sciences Landscape

Dow Chemical Company

Anchored in Sustainability

Concept Heidelberg

ECA Foundation Aims to Become Largest Pharma Association for GMP/GDP Compliance

Nova-Institut GmbH

Advanced Recycling Conference 2025: New Paths to the Circular Economy

Brenntag Downsizes Management Board, Retains Both Divisions

CHEManager International c/o Wiley-VCH GmbH

API Manufacturing

Easyfairs Deutschland GmbH

Leading the way. Driving results.

BIO Deutschland e.V.

German Biotech Days 2026: Biotechnology as The Key to Industrial Competitiveness

CHEManager c/o Wiley-VCH Verlag

Upcoming Virtual Events

Leading Transformation

Special Issue

Circular Plastics Economy

Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

IEDC Europe Indiana

DCAT - Drug, Chemical & Associated Technologies Association

Fitch Ratings

CONTINUUS Pharmaceuticals, Inc.

Camelot Management Consultants AG

Oracle Germany

GlaxoSmithKline (GSK) plc

Isomorphic Labs

SchüllerConsulting

Frost & Sullivan

Sanofi S.A.

Microinnova Engineering GmbH

Lilly Deutschland GmbH

Eli Lilly and Company